UK patients face losing access to “life-saving” medical cannabis product

UK patients face losing access to “life-saving” medical cannabis product
Cannabis Health News

Dozens of children and young people with epilepsy are faced with losing access to a “life-saving” medical cannabis product as imports are to be stopped. Patients who are prescribed a cannabis oil through private clinics in the UK have learned they will no longer be able to access this medication in what has been described as a “major setback” for families.  The MHRA has removed a compassionate licence for the importation of Celixir20, also known as NOIDECS, a whole-plant cannabis product which is currently being prescribed to over 30 children and young people with treatment-resistant epilepsy.  A number of adult patients who are also prescribed the product for symptoms such as chronic pain and anxiety, are also faced with having to find an alternative.  In an email to the co-founder of Medcan Support, Matt Hughes, whose son is one of those affected, the MHRA said the product, which is imported from Israeli company Bol Pharma, did not meet Good Manufacturing Practices (GMP) standards. “In the absence of assurances that Celixir 20 is manufactured at a facility operating to the same rigorous standards as other medicinal products, the MHRA is not able to process import notifications of this medicine on the grounds of patient safety,” the letter stated. Officials went on to advise Hughes to contact Charlie’s prescriber to find a “suitable alternative”. However, there is currently no other product on the market which is similar in strength and chemovar profile as Celixir20, which contains 20:1 CBD to THC. Charlie, now five, has a condition known as West syndrome, which at its worst caused him to experience over 100 seizures a day. He has been prescribed Celixir20 since June 2020 and according to Hughes has now been seizure-free for 150 days.  His parents fear that Charlie’s seizures will return if he…

Excerpt only …
READ MORE BELOW
Source : UK patients face losing access to “life-saving” medical cannabis product

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.